Compare APGE & DLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APGE | DLO |
|---|---|---|
| Founded | 2022 | 2013 |
| Country | United States | Uruguay |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.4B |
| IPO Year | 2023 | 2021 |
| Metric | APGE | DLO |
|---|---|---|
| Price | $134.08 | $14.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $109.67 | $17.25 |
| AVG Volume (30 Days) | ★ 5.4M | 3.2M |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $41.00 |
| Revenue Next Year | N/A | $26.98 |
| P/E Ratio | ★ N/A | $22.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.34 | $9.81 |
| 52 Week High | $134.35 | $16.78 |
| Indicator | APGE | DLO |
|---|---|---|
| Relative Strength Index (RSI) | 80.75 | 53.65 |
| Support Level | $80.52 | $13.21 |
| Resistance Level | N/A | $14.80 |
| Average True Range (ATR) | 0.43 | 0.61 |
| MACD | -1.69 | -0.08 |
| Stochastic Oscillator | 86.53 | 23.51 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company operates in a single operating segment, which is payment processing. The company's geographical segments include Latin America and Non-Latin America, with a majority of its revenue being generated from Brazil in the Latin America region.